Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a newer version of the page metadata. There are no visible changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-07T18:28:49.000Z thumbnail image
  2. Check
    20 days ago
    No Change Detected
  3. Check
    27 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:22:34.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    Revision labels were updated from v3.4.3 to v3.5.0. There are no visible changes to study details or content.
    Difference
    0.1%
    Check dated 2026-03-25T20:07:56.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:51:56.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Removed the funding-lapse notice and the previous Revision: v3.4.1 entry.
    Difference
    0.5%
    Check dated 2026-02-11T06:16:09.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Added a government funding notice about site status. Updated the revision to v3.4.1, replacing the previous v3.4.0 note.
    Difference
    0.5%
    Check dated 2026-02-04T04:41:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.